Alzheimer’s disease is one of the most prevalent cognitive diseases in the world with more than 30 million global cases. It affects your motor skills and function, memory and attention span, and self-control, causing a gradual cognitive decline. Currently, there’s no cure for Alzheimer’s disease or the subtypes of dementia. In recent years, however, research has indicated that psychedelic therapy may be effective in reducing the symptoms of the disease and slowing its progression. Psychedelics
Every business needs to have key performance indicators (KPIs) to measure its growth and progress. However, many new ventures struggle to meet their KPI targets which impacts their business’s success. Here’s why your psychedelic startup is struggling to meet KPI targets. Your KPIs Are Uninspiring & Unattainable One of the biggest reasons for startups failing to meet their KPI targets is that they set unrealistic goals. The KPIs are either too ambitious or lack ambition altogether. As
Psychedelic drugs have been the subject of all sorts of myths and misconceptions. From being dismissed as solely recreational drugs to being categorized as dangerous, they’ve been stigmatized by health professionals, regulatory bodies, and consumers alike. Here are a few common myths about psychedelics that you shouldn’t believe. They’re Party Drugs Let’s be honest; we’ve all heard of wild parties where psychedelics are used. This has led to the misconception that MDMA, LSD, psilocybin, and
Here are the Benefits For Using Psychedelics In Chronic Pain: theconscious
3 Reasons Why You Should Consider Setting Up a Psychedelic Medicine Business in 2021
Category: Uncategorised
The psychedelic industry has grown exponentially in the last couple of years and is expected to be one of the biggest industries in the next decade. Here’s why you should consider starting a psychedelic medicine business this year. Regulatory Issues Are Getting Resolved Several psychedelic drugs are categorized as Schedule 1 drugs in the United States, meaning that they’re “heavily controlled”. Consequently, the regulation of psychedelics has seen a murky road over the years, with the